Skip to main content
Article
Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study
Clinical Genitourinary Cancer (2009)
  • John A. Thompson, University of Washington
  • Timothy Kuzel, University Medical Center
  • Beverly J. Drucker, Memorial Sloan Kettering Cancer Center
  • Walter J. Urba, Providence Portland Medical Center
  • Ronald M. Bukowski, Cleveland Clinic
Publication Date
January 10, 2009
DOI
10.3816/CGC.2009.n.025
Citation Information
John A. Thompson, Timothy Kuzel, Beverly J. Drucker, Walter J. Urba, et al.. "Safety and Efficacy of PF-3512676 for the Treatment of Stage IV Renal Cell Carcinoma: An Open-Label, Multicenter Phase I/II Study" Clinical Genitourinary Cancer Vol. 7 Iss. 3 (2009)
Available at: http://works.bepress.com/walter-urba/177/